The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

COVID-19

Filter Newest Oldest Showing 21-40 of 57 results
Commentary / VOLUME 4, ISSUE 2, JUNE 2022

Management of COVID-19 Cases in Kosova

Salih Ahmeti and others

International collaborative consultations are significantly beneficial in combatting pandemics, although such opportunities were quite limited during the COVID-19 pandemic. We had the chance to convene with the experts to share experiences and review the practices in Kosova. Two days of expert consultation hybrid meeting […] Read More

Brief Report / VOLUME 4, ISSUE 2, JUNE 2022

SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly

Harika Öykü Dinç and others

Despite the decrease in incidence after having widespread vaccination programs, the COVID-19 pandemic continues to cause high morbidity and mortality in the world in its second year. Especially elderly people (over 65 years old), people with underlying health conditions, and healthcare workers (HCWs) are still at high risk for COVID-19 disease. Since […] Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

HIV and SARS‐Cov‐2 Co-Infection: A Local Perspective

Heval Can Bilek and Aydın Deveci

In early December 2019, interstitial pneumonia of unknown origin emerged in Wuhan, the capital of China’s Hubei province. The pathogen was identified as a novel beta coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease caused by SARS-CoV-2 was later named (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study

Ege Anıl Uçar and others

Rational use of medicines (RUM) has been a concern worldwide for half a century, and is of great importance, given that almost half of all prescribed drugs are irrational. The irrational use of drugs can be disastrous and may cause adverse events, creating a (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Fethiye Akgül and others

At the beginning of the 21st century, three deadly epidemics related to coronaviruses have struck the world. Severe acute respiratory syndrome (SARS) originated in 2002, Middle East respiratory syndrome (MERS) in 2012, and finally COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019. COVID-19 (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

COVID-19 in Elderly Patients: Risk Factors for Disease Severity

Pınar Korkmaz and others

At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It spread rapidly, resulting in a pandemic throughout the world. In February 2020, the World Health Organization (WHO) named the disease COVID-19. Studies reported that COVID-19 mostly progressed with asymptomatic (...) Read More

Commentary / VOLUME 3, ISSUE 3, DECEMBER 2021

Virtual Learning Opportunity During COVID-19 Pandemic: Comparison of Virtual (2021) and Face to Face (2019) Conferences of Turkish Society of Clinical Microbiology and Infectious Diseases

Önder Ergönül and others

About the last 10-year if not older, electronic learning as a training method in infectious diseases (ID) and clinical microbiology (CM) was defined as an area to be improved. In a survey published in 2017 by the European Society of Clinical Microbiology (...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

The Effects of Polypharmacy, Nutritional and Functional Status on the Progression of COVID-19 in Older Adults

Asiye Bahar Kaçmaz and others

The SARS-CoV-2 infection has influenced the whole world and every day, both the number of cases and deaths related to the COVID-19 pandemic continue to rise. Eighty-one percent of COVID-19 cases are mild, 14% are serious and 5% are critical. Although the overall mortality rate was 2.3%, mortality (...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

Infectivity of Adult and Pediatric COVID-19 Patients

Mahir Kapmaz and others

The clinical findings of SARS-CoV-2 infection are heterogeneous, and the duration of viral RNA shedding varies on the age of the patient, severity of the disease, and type of the sample. For that reason, a comprehensive analysis of the dynamics of viral shedding is critical for (...) Read More

Case Report / VOLUME 3, ISSUE 2, AUGUST 2021

First Report of SARS-CoV-2 Gamma Variant in Turkey

Mert Ahmet Kuşkucu and others

As viruses spread through a population, they mutate and change, leading to the evolution of slightly different forms or variants. SARS-CoV-2 has been mutating ever since it was first detected in Wuhan, China, in December 2019. While most of the mutations will not have a significant effect on the spread of the virus, some mutations or (...) Read More

Case Report / VOLUME 3, ISSUE 2, AUGUST 2021

Two Cases of COVID-19 Reinfection in Turkey

İrem Akdemir-Kalkan and others

SARS-CoV-2 has affected the whole world while the number of cases is increasing rapidly. Several reinfection cases have been reported with the rise in the number of infected people. It is important to study these reinfection cases as the knowledge gained can be used in critical decisions (...) Read More